Skip to content

Clinical trials

Glomerulonephritis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis Country / region: Hong Kong Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20091
20101
20121
20202
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong5
Novartis Pharmaceuticals2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Human Genome Sciences Inc., a GSK Company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Sanofi1
The George Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis12
Glomerulonephritis, IGA7
Kidney Diseases4
Lupus Erythematosus, Systemic3
Lupus Nephritis3
Proteinuria3
Renal Insufficiency, Chronic3
Autoimmune Diseases2
Nephritis2
Glomerulonephritis, Membranous1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.